Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2019
Headcount
6
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences
About
PeptiCanna has developed a novel patent-granted peptide that improves metabolic parameters for treating obesity and Diabetes type 2 without adverse central nervous system effects.
Q&A
- What is PeptiCanna's primary focus?
- PeptiCanna specializes in Health Tech & Life Sciences, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is PeptiCanna's core product or technology?
- PeptiCanna has developed a novel patent-granted peptide designed to improve metabolic parameters for treating obesity and Type 2 Diabetes without adverse central nervous system effects.
- When was PeptiCanna founded?
- PeptiCanna was founded in March 2019.
- What is the current operational status of PeptiCanna?
- PeptiCanna is currently inactive, having ceased operations in December 2019.
- Where is PeptiCanna headquartered?
- PeptiCanna is headquartered in Rosh Haayin, Center District, Israel.
- How many employees did PeptiCanna have?
- PeptiCanna had an employee count in the 1-10 range.
- Does PeptiCanna hold any patents?
- Yes, PeptiCanna holds one patent.
- Who is the founder of PeptiCanna?
- Andrea Heimann is the founder of PeptiCanna.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
obesitydrug-discoverydiabetespeptidestype-2-diabetespharmaceuticalsstealthmode
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2019-3 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Dec 2019 ceased to operate |